Jobnotifys.in : Latest Govt Jobs Online Form Result
About COVID-XBB.1.16 Variant in India : Symptoms, Spread, Treatments, Vaccines, Testing and Other details given below : .The latest COVID-19 variant, XBB.1.16, is sweeping the nation and now accounts for more than half of COVID-19 infections. This is likely because this particular variant is five times more contagious than the Omicron variant.The variants are mutating and forming new sub-variants – one of the highest mutated versions of the COVID virus in the Omicron variant. It comes with over 42 mutations in its spike protein, making it capable of evading the immune system of the human body. However, this is not it.
XBB.1.16 Variant 2023 Details
The XBB.1.16 is a mutant strain of SARS CoV 2, mainly of Omicron. Experts say that people who have already had COVID are likely to get reinfected by XBB.1.16, and those who have managed not to get COVID yet will likely catch this variant regardless of vaccination status. The first case of the XBB.1.16 Variant was found in January this year when two samples tested positive. In February, 140 samples of the XBB 1.16 variant were reported. In March, 207 XBB 1.16 variant samples have been found till now, the data revealed.
XBB.1.16 Symptoms
These include a runny nose, a sore throat and sneezing, as opposed to the original coronavirus strain which primarily caused a fever, a new and persistent cough, and a loss or change to sense of smell or taste.
- Fever or chills
- Cough
- Shortness of breath
- Feeling tired or exhausted
- muscle or body aches
- Sore throat
- A blocked or runny nose
- Loss of taste & Smell
- Feeling sick or being sick
- vomiting and diarrhoea
XBB.1.16 Variant Tests
The widely used PCR tests continue to detect infection, including infection with XBB.1.16 , as we have seen with other variants as well. Studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests.
XBB.1.16 Variant Treatments
Corticosteroids and IL6 Receptor Blockers will still be effective for managing patients with severe COVID-19. Other treatments will be assessed to see if they are still as effective given the changes to parts of the virus in the Omicron variant.
Vaccination is expected to provide important protection against severe disease and death caused by Omicron, as it does with the other variants still in circulation. Up to this point, the comparatively lower rate of hospitalizations and deaths from Omicron is in large part thanks to so many people in our Region already being vaccinated. Vaccination prompts the body’s immune response to the virus, which not only protects us from the variants currently in circulation including Omicron but is also likely to give protection from severe disease due to future mutations of Coronavirus.
Vaccines
Vaccination remains effective at preventing severe diseases, and individuals are strongly encouraged to be vaccinated and receive appropriate booster doses according to the latest COVID-19 vaccination recommendations.
Also Check
Contents
